nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—hypertension—type 2 diabetes mellitus	0.2	1	CtDrD
Candesartan—Irbesartan—type 2 diabetes mellitus	0.125	0.389	CrCtD
Candesartan—Valsartan—type 2 diabetes mellitus	0.106	0.33	CrCtD
Candesartan—Losartan—type 2 diabetes mellitus	0.0905	0.281	CrCtD
Candesartan—AGTR1—Valsartan—type 2 diabetes mellitus	0.0281	0.144	CbGbCtD
Candesartan—AGTR1—Irbesartan—type 2 diabetes mellitus	0.025	0.129	CbGbCtD
Candesartan—Forasartan—Irbesartan—type 2 diabetes mellitus	0.0163	0.0758	CrCrCtD
Candesartan—Valsartan—Irbesartan—type 2 diabetes mellitus	0.0163	0.0758	CrCrCtD
Candesartan—AGTR1—Losartan—type 2 diabetes mellitus	0.0161	0.0829	CbGbCtD
Candesartan—UGT1A3—Irbesartan—type 2 diabetes mellitus	0.0155	0.0797	CbGbCtD
Candesartan—Tasosartan—Irbesartan—type 2 diabetes mellitus	0.0144	0.067	CrCrCtD
Candesartan—Forasartan—Valsartan—type 2 diabetes mellitus	0.0139	0.0644	CrCrCtD
Candesartan—Irbesartan—Valsartan—type 2 diabetes mellitus	0.0139	0.0644	CrCrCtD
Candesartan—Azilsartan medoxomil—Losartan—type 2 diabetes mellitus	0.0137	0.0634	CrCrCtD
Candesartan—Telmisartan—Losartan—type 2 diabetes mellitus	0.0137	0.0634	CrCrCtD
Candesartan—Olmesartan—Irbesartan—type 2 diabetes mellitus	0.013	0.0602	CrCrCtD
Candesartan—Tasosartan—Valsartan—type 2 diabetes mellitus	0.0123	0.0569	CrCrCtD
Candesartan—Valsartan—Losartan—type 2 diabetes mellitus	0.0118	0.0548	CrCrCtD
Candesartan—Losartan—Irbesartan—type 2 diabetes mellitus	0.0118	0.0548	CrCrCtD
Candesartan—Irbesartan—Losartan—type 2 diabetes mellitus	0.0118	0.0548	CrCrCtD
Candesartan—Forasartan—Losartan—type 2 diabetes mellitus	0.0118	0.0548	CrCrCtD
Candesartan—Olmesartan—Valsartan—type 2 diabetes mellitus	0.011	0.0512	CrCrCtD
Candesartan—Tasosartan—Losartan—type 2 diabetes mellitus	0.0104	0.0484	CrCrCtD
Candesartan—Losartan—Valsartan—type 2 diabetes mellitus	0.01	0.0466	CrCrCtD
Candesartan—UGT1A3—Losartan—type 2 diabetes mellitus	0.00999	0.0514	CbGbCtD
Candesartan—Olmesartan—Losartan—type 2 diabetes mellitus	0.00938	0.0435	CrCrCtD
Candesartan—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.00677	0.0348	CbGbCtD
Candesartan—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.00677	0.0348	CbGbCtD
Candesartan—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.00625	0.0321	CbGbCtD
Candesartan—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0054	0.0278	CbGbCtD
Candesartan—PTGS1—Nateglinide—type 2 diabetes mellitus	0.00513	0.0264	CbGbCtD
Candesartan—PTGS1—Irbesartan—type 2 diabetes mellitus	0.00492	0.0253	CbGbCtD
Candesartan—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00432	0.0222	CbGbCtD
Candesartan—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0041	0.0211	CbGbCtD
Candesartan—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00391	0.0201	CbGbCtD
Candesartan—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00377	0.0194	CbGbCtD
Candesartan—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00366	0.0188	CbGbCtD
Candesartan—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00361	0.0185	CbGbCtD
Candesartan—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00348	0.0179	CbGbCtD
Candesartan—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00345	0.0177	CbGbCtD
Candesartan—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0032	0.0165	CbGbCtD
Candesartan—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00284	0.0146	CbGbCtD
Candesartan—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00272	0.014	CbGbCtD
Candesartan—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00272	0.014	CbGbCtD
Candesartan—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00264	0.0136	CbGbCtD
Candesartan—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00251	0.0129	CbGbCtD
Candesartan—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00243	0.0125	CbGbCtD
Candesartan—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00222	0.0114	CbGbCtD
Candesartan—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00207	0.0106	CbGbCtD
Candesartan—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00198	0.0102	CbGbCtD
Candesartan—CYP2C8—Losartan—type 2 diabetes mellitus	0.00183	0.00941	CbGbCtD
Candesartan—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00182	0.00934	CbGbCtD
Candesartan—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00139	0.00717	CbGbCtD
Candesartan—ABCB1—Glyburide—type 2 diabetes mellitus	0.00135	0.00696	CbGbCtD
Candesartan—CYP2C9—Losartan—type 2 diabetes mellitus	0.00128	0.00656	CbGbCtD
Candesartan—ABCB1—Losartan—type 2 diabetes mellitus	0.00124	0.00637	CbGbCtD
Candesartan—AGTR1—artery—type 2 diabetes mellitus	0.000436	0.145	CbGeAlD
Candesartan—Tasosartan—AGTR2—type 2 diabetes mellitus	0.0004	0.264	CrCbGaD
Candesartan—AGTR1—endothelium—type 2 diabetes mellitus	0.000368	0.122	CbGeAlD
Candesartan—Pranlukast—NFKB1—type 2 diabetes mellitus	0.000269	0.178	CrCbGaD
Candesartan—UGT1A3—liver—type 2 diabetes mellitus	0.00022	0.0729	CbGeAlD
Candesartan—PTGS1—artery—type 2 diabetes mellitus	0.000192	0.0636	CbGeAlD
Candesartan—AGTR1—nephron tubule—type 2 diabetes mellitus	0.000169	0.0559	CbGeAlD
Candesartan—PTGS1—endothelium—type 2 diabetes mellitus	0.000162	0.0537	CbGeAlD
Candesartan—AGTR1—cardiovascular system—type 2 diabetes mellitus	0.000152	0.0502	CbGeAlD
Candesartan—AGTR1—kidney—type 2 diabetes mellitus	0.000148	0.0492	CbGeAlD
Candesartan—AGTR1—cortex of kidney—type 2 diabetes mellitus	0.000144	0.0479	CbGeAlD
Candesartan—Irbesartan—EDNRA—type 2 diabetes mellitus	0.000137	0.0902	CrCbGaD
Candesartan—AGTR1—adipose tissue—type 2 diabetes mellitus	0.000134	0.0443	CbGeAlD
Candesartan—AGTR1—liver—type 2 diabetes mellitus	9.37e-05	0.0311	CbGeAlD
Candesartan—Pranlukast—ABCC2—type 2 diabetes mellitus	9.06e-05	0.0598	CrCbGaD
Candesartan—Pranlukast—TNF—type 2 diabetes mellitus	8.25e-05	0.0545	CrCbGaD
Candesartan—CYP2C8—kidney—type 2 diabetes mellitus	8.04e-05	0.0266	CbGeAlD
Candesartan—CYP2C9—cardiovascular system—type 2 diabetes mellitus	7.3e-05	0.0242	CbGeAlD
Candesartan—Olmesartan—ABCC2—type 2 diabetes mellitus	7.19e-05	0.0475	CrCbGaD
Candesartan—Telmisartan—PPARG—type 2 diabetes mellitus	7.11e-05	0.047	CrCbGaD
Candesartan—Telmisartan—ABCC2—type 2 diabetes mellitus	6.94e-05	0.0458	CrCbGaD
Candesartan—Deferasirox—CYP3A4—type 2 diabetes mellitus	6.68e-05	0.0441	CrCbGaD
Candesartan—PTGS1—cardiovascular system—type 2 diabetes mellitus	6.66e-05	0.0221	CbGeAlD
Candesartan—PTGS1—kidney—type 2 diabetes mellitus	6.52e-05	0.0216	CbGeAlD
Candesartan—PTGS1—adipose tissue—type 2 diabetes mellitus	5.88e-05	0.0195	CbGeAlD
Candesartan—ABCB1—islet of Langerhans—type 2 diabetes mellitus	5.45e-05	0.0181	CbGeAlD
Candesartan—CYP2C8—liver—type 2 diabetes mellitus	5.08e-05	0.0168	CbGeAlD
Candesartan—ABCB1—retina—type 2 diabetes mellitus	4.66e-05	0.0154	CbGeAlD
Candesartan—CYP2C9—liver—type 2 diabetes mellitus	4.51e-05	0.015	CbGeAlD
Candesartan—ABCB1—nephron tubule—type 2 diabetes mellitus	4.39e-05	0.0145	CbGeAlD
Candesartan—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	4.17e-05	0.00093	CcSEcCtD
Candesartan—Asthenia—Sitagliptin—type 2 diabetes mellitus	4.16e-05	0.000929	CcSEcCtD
Candesartan—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	4.15e-05	0.000926	CcSEcCtD
Candesartan—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	4.15e-05	0.000926	CcSEcCtD
Candesartan—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	4.14e-05	0.000925	CcSEcCtD
Candesartan—Chest pain—Valsartan—type 2 diabetes mellitus	4.13e-05	0.000922	CcSEcCtD
Candesartan—Myalgia—Valsartan—type 2 diabetes mellitus	4.13e-05	0.000922	CcSEcCtD
Candesartan—Arthralgia—Valsartan—type 2 diabetes mellitus	4.13e-05	0.000922	CcSEcCtD
Candesartan—Dizziness—Glipizide—type 2 diabetes mellitus	4.12e-05	0.00092	CcSEcCtD
Candesartan—Pruritus—Glimepiride—type 2 diabetes mellitus	4.12e-05	0.000919	CcSEcCtD
Candesartan—Anxiety—Valsartan—type 2 diabetes mellitus	4.12e-05	0.000918	CcSEcCtD
Candesartan—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	4.09e-05	0.000912	CcSEcCtD
Candesartan—Chest pain—Orlistat—type 2 diabetes mellitus	4.08e-05	0.000911	CcSEcCtD
Candesartan—Myalgia—Orlistat—type 2 diabetes mellitus	4.08e-05	0.000911	CcSEcCtD
Candesartan—Anxiety—Orlistat—type 2 diabetes mellitus	4.07e-05	0.000907	CcSEcCtD
Candesartan—Epistaxis—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000906	CcSEcCtD
Candesartan—Sinusitis—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000901	CcSEcCtD
Candesartan—Hypotension—Gliclazide—type 2 diabetes mellitus	4.03e-05	0.000899	CcSEcCtD
Candesartan—Agranulocytosis—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000896	CcSEcCtD
Candesartan—Pranlukast—CYP3A4—type 2 diabetes mellitus	4e-05	0.0264	CrCbGaD
Candesartan—Diarrhoea—Glimepiride—type 2 diabetes mellitus	3.98e-05	0.000888	CcSEcCtD
Candesartan—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	3.97e-05	0.000886	CcSEcCtD
Candesartan—Vomiting—Glipizide—type 2 diabetes mellitus	3.97e-05	0.000885	CcSEcCtD
Candesartan—Dizziness—Pioglitazone—type 2 diabetes mellitus	3.95e-05	0.000881	CcSEcCtD
Candesartan—ABCB1—cardiovascular system—type 2 diabetes mellitus	3.94e-05	0.0131	CbGeAlD
Candesartan—Rash—Glipizide—type 2 diabetes mellitus	3.93e-05	0.000877	CcSEcCtD
Candesartan—Dermatitis—Glipizide—type 2 diabetes mellitus	3.93e-05	0.000877	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	3.93e-05	0.000876	CcSEcCtD
Candesartan—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	3.93e-05	0.000876	CcSEcCtD
Candesartan—Headache—Glipizide—type 2 diabetes mellitus	3.91e-05	0.000872	CcSEcCtD
Candesartan—Palpitations—Metformin—type 2 diabetes mellitus	3.91e-05	0.000871	CcSEcCtD
Candesartan—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	3.88e-05	0.000865	CcSEcCtD
Candesartan—Paraesthesia—Gliclazide—type 2 diabetes mellitus	3.87e-05	0.000863	CcSEcCtD
Candesartan—Hepatitis—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000862	CcSEcCtD
Candesartan—Anaemia—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.00086	CcSEcCtD
Candesartan—ABCB1—kidney—type 2 diabetes mellitus	3.85e-05	0.0128	CbGeAlD
Candesartan—Dizziness—Glimepiride—type 2 diabetes mellitus	3.85e-05	0.000859	CcSEcCtD
Candesartan—Dyspnoea—Gliclazide—type 2 diabetes mellitus	3.84e-05	0.000857	CcSEcCtD
Candesartan—Dizziness—Sitagliptin—type 2 diabetes mellitus	3.84e-05	0.000856	CcSEcCtD
Candesartan—Somnolence—Gliclazide—type 2 diabetes mellitus	3.83e-05	0.000855	CcSEcCtD
Candesartan—ABCB1—pancreas—type 2 diabetes mellitus	3.83e-05	0.0127	CbGeAlD
Candesartan—Hypertension—Metformin—type 2 diabetes mellitus	3.82e-05	0.000851	CcSEcCtD
Candesartan—Urticaria—Glyburide—type 2 diabetes mellitus	3.81e-05	0.000851	CcSEcCtD
Candesartan—Angioedema—Irbesartan—type 2 diabetes mellitus	3.81e-05	0.00085	CcSEcCtD
Candesartan—Oedema peripheral—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000849	CcSEcCtD
Candesartan—Back pain—Losartan—type 2 diabetes mellitus	3.8e-05	0.000847	CcSEcCtD
Candesartan—Abdominal pain—Glyburide—type 2 diabetes mellitus	3.8e-05	0.000847	CcSEcCtD
Candesartan—Dyspepsia—Gliclazide—type 2 diabetes mellitus	3.79e-05	0.000846	CcSEcCtD
Candesartan—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	3.78e-05	0.000844	CcSEcCtD
Candesartan—Asthenia—Bromocriptine—type 2 diabetes mellitus	3.77e-05	0.00084	CcSEcCtD
Candesartan—Tasosartan—CYP3A4—type 2 diabetes mellitus	3.76e-05	0.0248	CrCbGaD
Candesartan—Myalgia—Metformin—type 2 diabetes mellitus	3.76e-05	0.000839	CcSEcCtD
Candesartan—Chest pain—Metformin—type 2 diabetes mellitus	3.76e-05	0.000839	CcSEcCtD
Candesartan—ABCB1—cortex of kidney—type 2 diabetes mellitus	3.75e-05	0.0124	CbGeAlD
Candesartan—Vertigo—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.000836	CcSEcCtD
Candesartan—Headache—Pioglitazone—type 2 diabetes mellitus	3.74e-05	0.000835	CcSEcCtD
Candesartan—Irbesartan—CYP1A2—type 2 diabetes mellitus	3.73e-05	0.0247	CrCbGaD
Candesartan—Leukopenia—Irbesartan—type 2 diabetes mellitus	3.73e-05	0.000833	CcSEcCtD
Candesartan—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	3.72e-05	0.00083	CcSEcCtD
Candesartan—Fatigue—Gliclazide—type 2 diabetes mellitus	3.72e-05	0.000829	CcSEcCtD
Candesartan—Nausea—Glipizide—type 2 diabetes mellitus	3.71e-05	0.000826	CcSEcCtD
Candesartan—Vomiting—Glimepiride—type 2 diabetes mellitus	3.7e-05	0.000826	CcSEcCtD
Candesartan—Hypotension—Valsartan—type 2 diabetes mellitus	3.7e-05	0.000826	CcSEcCtD
Candesartan—Vomiting—Sitagliptin—type 2 diabetes mellitus	3.69e-05	0.000823	CcSEcCtD
Candesartan—Rash—Glimepiride—type 2 diabetes mellitus	3.67e-05	0.000819	CcSEcCtD
Candesartan—Dermatitis—Glimepiride—type 2 diabetes mellitus	3.67e-05	0.000818	CcSEcCtD
Candesartan—Rash—Sitagliptin—type 2 diabetes mellitus	3.66e-05	0.000816	CcSEcCtD
Candesartan—Dermatitis—Sitagliptin—type 2 diabetes mellitus	3.66e-05	0.000815	CcSEcCtD
Candesartan—Headache—Glimepiride—type 2 diabetes mellitus	3.65e-05	0.000813	CcSEcCtD
Candesartan—Cough—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000812	CcSEcCtD
Candesartan—Headache—Sitagliptin—type 2 diabetes mellitus	3.64e-05	0.000811	CcSEcCtD
Candesartan—Anaemia—Losartan—type 2 diabetes mellitus	3.63e-05	0.000809	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	3.61e-05	0.000805	CcSEcCtD
Candesartan—Hypertension—Irbesartan—type 2 diabetes mellitus	3.6e-05	0.000803	CcSEcCtD
Candesartan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	3.59e-05	0.000801	CcSEcCtD
Candesartan—Angioedema—Losartan—type 2 diabetes mellitus	3.59e-05	0.0008	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000795	CcSEcCtD
Candesartan—Paraesthesia—Valsartan—type 2 diabetes mellitus	3.56e-05	0.000793	CcSEcCtD
Candesartan—Chest pain—Irbesartan—type 2 diabetes mellitus	3.55e-05	0.000792	CcSEcCtD
Candesartan—Arthralgia—Irbesartan—type 2 diabetes mellitus	3.55e-05	0.000792	CcSEcCtD
Candesartan—Myalgia—Irbesartan—type 2 diabetes mellitus	3.55e-05	0.000792	CcSEcCtD
Candesartan—Anxiety—Irbesartan—type 2 diabetes mellitus	3.54e-05	0.000789	CcSEcCtD
Candesartan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	3.53e-05	0.000788	CcSEcCtD
Candesartan—Dyspnoea—Valsartan—type 2 diabetes mellitus	3.53e-05	0.000788	CcSEcCtD
Candesartan—Vertigo—Losartan—type 2 diabetes mellitus	3.53e-05	0.000787	CcSEcCtD
Candesartan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.53e-05	0.000786	CcSEcCtD
Candesartan—Somnolence—Valsartan—type 2 diabetes mellitus	3.52e-05	0.000785	CcSEcCtD
Candesartan—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.51e-05	0.000784	CcSEcCtD
Candesartan—Leukopenia—Losartan—type 2 diabetes mellitus	3.51e-05	0.000784	CcSEcCtD
Candesartan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	3.49e-05	0.000778	CcSEcCtD
Candesartan—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.49e-05	0.000778	CcSEcCtD
Candesartan—ABCB1—adipose tissue—type 2 diabetes mellitus	3.47e-05	0.0115	CbGeAlD
Candesartan—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.47e-05	0.000775	CcSEcCtD
Candesartan—Palpitations—Losartan—type 2 diabetes mellitus	3.47e-05	0.000774	CcSEcCtD
Candesartan—Nausea—Glimepiride—type 2 diabetes mellitus	3.46e-05	0.000771	CcSEcCtD
Candesartan—Nausea—Sitagliptin—type 2 diabetes mellitus	3.45e-05	0.000769	CcSEcCtD
Candesartan—Dyspepsia—Orlistat—type 2 diabetes mellitus	3.44e-05	0.000768	CcSEcCtD
Candesartan—Asthenia—Glyburide—type 2 diabetes mellitus	3.44e-05	0.000768	CcSEcCtD
Candesartan—Cough—Losartan—type 2 diabetes mellitus	3.42e-05	0.000764	CcSEcCtD
Candesartan—Urticaria—Gliclazide—type 2 diabetes mellitus	3.42e-05	0.000764	CcSEcCtD
Candesartan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	3.42e-05	0.000763	CcSEcCtD
Candesartan—Fatigue—Valsartan—type 2 diabetes mellitus	3.41e-05	0.000762	CcSEcCtD
Candesartan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	3.41e-05	0.00076	CcSEcCtD
Candesartan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.41e-05	0.00076	CcSEcCtD
Candesartan—Pruritus—Glyburide—type 2 diabetes mellitus	3.4e-05	0.000758	CcSEcCtD
Candesartan—Losartan—ACE—type 2 diabetes mellitus	3.39e-05	0.0224	CrCbGaD
Candesartan—Mental disorder—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000755	CcSEcCtD
Candesartan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.38e-05	0.000754	CcSEcCtD
Candesartan—Fatigue—Orlistat—type 2 diabetes mellitus	3.37e-05	0.000753	CcSEcCtD
Candesartan—Hypotension—Metformin—type 2 diabetes mellitus	3.37e-05	0.000752	CcSEcCtD
Candesartan—Malnutrition—Ramipril—type 2 diabetes mellitus	3.37e-05	0.000751	CcSEcCtD
Candesartan—Arthralgia—Losartan—type 2 diabetes mellitus	3.34e-05	0.000745	CcSEcCtD
Candesartan—Myalgia—Losartan—type 2 diabetes mellitus	3.34e-05	0.000745	CcSEcCtD
Candesartan—Chest pain—Losartan—type 2 diabetes mellitus	3.34e-05	0.000745	CcSEcCtD
Candesartan—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.34e-05	0.000745	CcSEcCtD
Candesartan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.33e-05	0.000743	CcSEcCtD
Candesartan—Anxiety—Losartan—type 2 diabetes mellitus	3.33e-05	0.000743	CcSEcCtD
Candesartan—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000741	CcSEcCtD
Candesartan—Rash—Bromocriptine—type 2 diabetes mellitus	3.31e-05	0.000739	CcSEcCtD
Candesartan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.31e-05	0.000738	CcSEcCtD
Candesartan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.29e-05	0.000734	CcSEcCtD
Candesartan—Headache—Bromocriptine—type 2 diabetes mellitus	3.29e-05	0.000734	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.29e-05	0.000733	CcSEcCtD
Candesartan—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.28e-05	0.000733	CcSEcCtD
Candesartan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.24e-05	0.000722	CcSEcCtD
Candesartan—Paraesthesia—Metformin—type 2 diabetes mellitus	3.24e-05	0.000722	CcSEcCtD
Candesartan—Dyspnoea—Metformin—type 2 diabetes mellitus	3.22e-05	0.000717	CcSEcCtD
Candesartan—Somnolence—Metformin—type 2 diabetes mellitus	3.21e-05	0.000715	CcSEcCtD
Candesartan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.2e-05	0.000714	CcSEcCtD
Candesartan—Hypotension—Irbesartan—type 2 diabetes mellitus	3.18e-05	0.000709	CcSEcCtD
Candesartan—Dyspepsia—Metformin—type 2 diabetes mellitus	3.17e-05	0.000708	CcSEcCtD
Candesartan—Urticaria—Valsartan—type 2 diabetes mellitus	3.15e-05	0.000702	CcSEcCtD
Candesartan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.14e-05	0.0007	CcSEcCtD
Candesartan—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.13e-05	0.000698	CcSEcCtD
Candesartan—Tachycardia—Losartan—type 2 diabetes mellitus	3.13e-05	0.000697	CcSEcCtD
Candesartan—Nausea—Bromocriptine—type 2 diabetes mellitus	3.12e-05	0.000696	CcSEcCtD
Candesartan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.11e-05	0.000695	CcSEcCtD
Candesartan—Fatigue—Metformin—type 2 diabetes mellitus	3.11e-05	0.000694	CcSEcCtD
Candesartan—Urticaria—Orlistat—type 2 diabetes mellitus	3.11e-05	0.000693	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.000692	CcSEcCtD
Candesartan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.1e-05	0.000691	CcSEcCtD
Candesartan—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.09e-05	0.00069	CcSEcCtD
Candesartan—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.09e-05	0.00069	CcSEcCtD
Candesartan—Asthenia—Gliclazide—type 2 diabetes mellitus	3.09e-05	0.00069	CcSEcCtD
Candesartan—Angioedema—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000686	CcSEcCtD
Candesartan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.06e-05	0.000682	CcSEcCtD
Candesartan—Vomiting—Glyburide—type 2 diabetes mellitus	3.05e-05	0.000681	CcSEcCtD
Candesartan—Pruritus—Gliclazide—type 2 diabetes mellitus	3.05e-05	0.00068	CcSEcCtD
Candesartan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.03e-05	0.000677	CcSEcCtD
Candesartan—Rash—Glyburide—type 2 diabetes mellitus	3.03e-05	0.000675	CcSEcCtD
Candesartan—Somnolence—Irbesartan—type 2 diabetes mellitus	3.03e-05	0.000675	CcSEcCtD
Candesartan—Dermatitis—Glyburide—type 2 diabetes mellitus	3.02e-05	0.000675	CcSEcCtD
Candesartan—Vertigo—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000674	CcSEcCtD
Candesartan—Leukopenia—Ramipril—type 2 diabetes mellitus	3.01e-05	0.000672	CcSEcCtD
Candesartan—Headache—Glyburide—type 2 diabetes mellitus	3.01e-05	0.000671	CcSEcCtD
Candesartan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3e-05	0.000668	CcSEcCtD
Candesartan—Hypotension—Losartan—type 2 diabetes mellitus	2.99e-05	0.000668	CcSEcCtD
Candesartan—Palpitations—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000663	CcSEcCtD
Candesartan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.95e-05	0.000658	CcSEcCtD
Candesartan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.95e-05	0.000658	CcSEcCtD
Candesartan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000655	CcSEcCtD
Candesartan—Cough—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000655	CcSEcCtD
Candesartan—Fatigue—Irbesartan—type 2 diabetes mellitus	2.93e-05	0.000655	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.92e-05	0.000651	CcSEcCtD
Candesartan—Paraesthesia—Losartan—type 2 diabetes mellitus	2.88e-05	0.000642	CcSEcCtD
Candesartan—Urticaria—Metformin—type 2 diabetes mellitus	2.87e-05	0.000639	CcSEcCtD
Candesartan—Chest pain—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000639	CcSEcCtD
Candesartan—Arthralgia—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000639	CcSEcCtD
Candesartan—Myalgia—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000639	CcSEcCtD
Candesartan—Dyspnoea—Losartan—type 2 diabetes mellitus	2.86e-05	0.000637	CcSEcCtD
Candesartan—Anxiety—Ramipril—type 2 diabetes mellitus	2.86e-05	0.000637	CcSEcCtD
Candesartan—Nausea—Glyburide—type 2 diabetes mellitus	2.85e-05	0.000636	CcSEcCtD
Candesartan—Abdominal pain—Metformin—type 2 diabetes mellitus	2.85e-05	0.000636	CcSEcCtD
Candesartan—Dizziness—Gliclazide—type 2 diabetes mellitus	2.85e-05	0.000636	CcSEcCtD
Candesartan—Somnolence—Losartan—type 2 diabetes mellitus	2.85e-05	0.000635	CcSEcCtD
Candesartan—Valsartan—ALB—type 2 diabetes mellitus	2.85e-05	0.0188	CrCbGaD
Candesartan—Asthenia—Valsartan—type 2 diabetes mellitus	2.84e-05	0.000634	CcSEcCtD
Candesartan—Dyspepsia—Losartan—type 2 diabetes mellitus	2.82e-05	0.000629	CcSEcCtD
Candesartan—Asthenia—Orlistat—type 2 diabetes mellitus	2.81e-05	0.000626	CcSEcCtD
Candesartan—Pruritus—Valsartan—type 2 diabetes mellitus	2.8e-05	0.000625	CcSEcCtD
Candesartan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.78e-05	0.000621	CcSEcCtD
Candesartan—Pruritus—Orlistat—type 2 diabetes mellitus	2.77e-05	0.000618	CcSEcCtD
Candesartan—Fatigue—Losartan—type 2 diabetes mellitus	2.76e-05	0.000616	CcSEcCtD
Candesartan—Vomiting—Gliclazide—type 2 diabetes mellitus	2.74e-05	0.000611	CcSEcCtD
Candesartan—Rash—Gliclazide—type 2 diabetes mellitus	2.72e-05	0.000606	CcSEcCtD
Candesartan—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.72e-05	0.000606	CcSEcCtD
Candesartan—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.71e-05	0.000604	CcSEcCtD
Candesartan—Urticaria—Irbesartan—type 2 diabetes mellitus	2.7e-05	0.000603	CcSEcCtD
Candesartan—Headache—Gliclazide—type 2 diabetes mellitus	2.7e-05	0.000602	CcSEcCtD
Candesartan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.69e-05	0.0006	CcSEcCtD
Candesartan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.69e-05	0.0006	CcSEcCtD
Candesartan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.69e-05	0.0006	CcSEcCtD
Candesartan—Tachycardia—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000598	CcSEcCtD
Candesartan—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.68e-05	0.000597	CcSEcCtD
Candesartan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000592	CcSEcCtD
Candesartan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.62e-05	0.000584	CcSEcCtD
Candesartan—Dizziness—Valsartan—type 2 diabetes mellitus	2.62e-05	0.000584	CcSEcCtD
Candesartan—Dizziness—Orlistat—type 2 diabetes mellitus	2.59e-05	0.000577	CcSEcCtD
Candesartan—Asthenia—Metformin—type 2 diabetes mellitus	2.59e-05	0.000577	CcSEcCtD
Candesartan—Hypotension—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000572	CcSEcCtD
Candesartan—Nausea—Gliclazide—type 2 diabetes mellitus	2.56e-05	0.000571	CcSEcCtD
Candesartan—Pruritus—Metformin—type 2 diabetes mellitus	2.55e-05	0.000569	CcSEcCtD
Candesartan—Urticaria—Losartan—type 2 diabetes mellitus	2.54e-05	0.000568	CcSEcCtD
Candesartan—Body temperature increased—Losartan—type 2 diabetes mellitus	2.53e-05	0.000565	CcSEcCtD
Candesartan—Abdominal pain—Losartan—type 2 diabetes mellitus	2.53e-05	0.000565	CcSEcCtD
Candesartan—Vomiting—Valsartan—type 2 diabetes mellitus	2.52e-05	0.000562	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000558	CcSEcCtD
Candesartan—Rash—Valsartan—type 2 diabetes mellitus	2.5e-05	0.000557	CcSEcCtD
Candesartan—Dermatitis—Valsartan—type 2 diabetes mellitus	2.49e-05	0.000557	CcSEcCtD
Candesartan—Vomiting—Orlistat—type 2 diabetes mellitus	2.49e-05	0.000555	CcSEcCtD
Candesartan—Headache—Valsartan—type 2 diabetes mellitus	2.48e-05	0.000553	CcSEcCtD
Candesartan—Irbesartan—CYP3A4—type 2 diabetes mellitus	2.47e-05	0.0163	CrCbGaD
Candesartan—Diarrhoea—Metformin—type 2 diabetes mellitus	2.47e-05	0.00055	CcSEcCtD
Candesartan—Rash—Orlistat—type 2 diabetes mellitus	2.47e-05	0.00055	CcSEcCtD
Candesartan—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.47e-05	0.00055	CcSEcCtD
Candesartan—Dermatitis—Orlistat—type 2 diabetes mellitus	2.47e-05	0.00055	CcSEcCtD
Candesartan—Headache—Orlistat—type 2 diabetes mellitus	2.45e-05	0.000547	CcSEcCtD
Candesartan—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000546	CcSEcCtD
Candesartan—Asthenia—Irbesartan—type 2 diabetes mellitus	2.44e-05	0.000545	CcSEcCtD
Candesartan—Somnolence—Ramipril—type 2 diabetes mellitus	2.44e-05	0.000545	CcSEcCtD
Candesartan—ABCB1—liver—type 2 diabetes mellitus	2.44e-05	0.00808	CbGeAlD
Candesartan—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.42e-05	0.000539	CcSEcCtD
Candesartan—Pruritus—Irbesartan—type 2 diabetes mellitus	2.41e-05	0.000537	CcSEcCtD
Candesartan—Losartan—CYP1A2—type 2 diabetes mellitus	2.41e-05	0.0159	CrCbGaD
Candesartan—Dizziness—Metformin—type 2 diabetes mellitus	2.39e-05	0.000532	CcSEcCtD
Candesartan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000529	CcSEcCtD
Candesartan—Fatigue—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000528	CcSEcCtD
Candesartan—Nausea—Valsartan—type 2 diabetes mellitus	2.35e-05	0.000525	CcSEcCtD
Candesartan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.33e-05	0.000519	CcSEcCtD
Candesartan—Nausea—Orlistat—type 2 diabetes mellitus	2.32e-05	0.000519	CcSEcCtD
Candesartan—Asthenia—Losartan—type 2 diabetes mellitus	2.3e-05	0.000513	CcSEcCtD
Candesartan—Vomiting—Metformin—type 2 diabetes mellitus	2.29e-05	0.000512	CcSEcCtD
Candesartan—Rash—Metformin—type 2 diabetes mellitus	2.27e-05	0.000507	CcSEcCtD
Candesartan—Dermatitis—Metformin—type 2 diabetes mellitus	2.27e-05	0.000507	CcSEcCtD
Candesartan—Pruritus—Losartan—type 2 diabetes mellitus	2.27e-05	0.000505	CcSEcCtD
Candesartan—Headache—Metformin—type 2 diabetes mellitus	2.26e-05	0.000504	CcSEcCtD
Candesartan—Dizziness—Irbesartan—type 2 diabetes mellitus	2.25e-05	0.000502	CcSEcCtD
Candesartan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.25e-05	0.000501	CcSEcCtD
Candesartan—Diarrhoea—Losartan—type 2 diabetes mellitus	2.19e-05	0.000489	CcSEcCtD
Candesartan—Urticaria—Ramipril—type 2 diabetes mellitus	2.18e-05	0.000487	CcSEcCtD
Candesartan—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.17e-05	0.000484	CcSEcCtD
Candesartan—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.17e-05	0.000484	CcSEcCtD
Candesartan—Vomiting—Irbesartan—type 2 diabetes mellitus	2.16e-05	0.000483	CcSEcCtD
Candesartan—Rash—Irbesartan—type 2 diabetes mellitus	2.15e-05	0.000479	CcSEcCtD
Candesartan—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.14e-05	0.000478	CcSEcCtD
Candesartan—Nausea—Metformin—type 2 diabetes mellitus	2.14e-05	0.000478	CcSEcCtD
Candesartan—Headache—Irbesartan—type 2 diabetes mellitus	2.13e-05	0.000476	CcSEcCtD
Candesartan—Dizziness—Losartan—type 2 diabetes mellitus	2.12e-05	0.000472	CcSEcCtD
Candesartan—Vomiting—Losartan—type 2 diabetes mellitus	2.04e-05	0.000454	CcSEcCtD
Candesartan—Nausea—Irbesartan—type 2 diabetes mellitus	2.02e-05	0.000451	CcSEcCtD
Candesartan—Rash—Losartan—type 2 diabetes mellitus	2.02e-05	0.00045	CcSEcCtD
Candesartan—Dermatitis—Losartan—type 2 diabetes mellitus	2.02e-05	0.00045	CcSEcCtD
Candesartan—Headache—Losartan—type 2 diabetes mellitus	2.01e-05	0.000448	CcSEcCtD
Candesartan—Asthenia—Ramipril—type 2 diabetes mellitus	1.97e-05	0.00044	CcSEcCtD
Candesartan—Pruritus—Ramipril—type 2 diabetes mellitus	1.94e-05	0.000433	CcSEcCtD
Candesartan—Nausea—Losartan—type 2 diabetes mellitus	1.9e-05	0.000424	CcSEcCtD
Candesartan—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.88e-05	0.000419	CcSEcCtD
Candesartan—Dizziness—Ramipril—type 2 diabetes mellitus	1.82e-05	0.000405	CcSEcCtD
Candesartan—Vomiting—Ramipril—type 2 diabetes mellitus	1.75e-05	0.00039	CcSEcCtD
Candesartan—Rash—Ramipril—type 2 diabetes mellitus	1.73e-05	0.000386	CcSEcCtD
Candesartan—Dermatitis—Ramipril—type 2 diabetes mellitus	1.73e-05	0.000386	CcSEcCtD
Candesartan—Headache—Ramipril—type 2 diabetes mellitus	1.72e-05	0.000384	CcSEcCtD
Candesartan—Nausea—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000364	CcSEcCtD
Candesartan—Losartan—CYP3A4—type 2 diabetes mellitus	1.59e-05	0.0105	CrCbGaD
Candesartan—Losartan—ALB—type 2 diabetes mellitus	1.39e-05	0.00918	CrCbGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.96e-06	0.000158	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.93e-06	0.000157	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	2.92e-06	0.000156	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.92e-06	0.000156	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—type 2 diabetes mellitus	2.92e-06	0.000156	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.92e-06	0.000156	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.91e-06	0.000155	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	2.89e-06	0.000154	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.89e-06	0.000154	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	2.88e-06	0.000154	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	2.87e-06	0.000153	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	2.87e-06	0.000153	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	2.87e-06	0.000153	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	2.87e-06	0.000153	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.87e-06	0.000153	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—INS—type 2 diabetes mellitus	2.86e-06	0.000153	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.86e-06	0.000153	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.84e-06	0.000151	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.83e-06	0.000151	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.8e-06	0.000149	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.79e-06	0.000149	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.78e-06	0.000148	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.74e-06	0.000146	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	2.71e-06	0.000145	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.71e-06	0.000145	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	2.7e-06	0.000144	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.7e-06	0.000144	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	2.68e-06	0.000143	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.66e-06	0.000142	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.65e-06	0.000142	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.64e-06	0.000141	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—type 2 diabetes mellitus	2.63e-06	0.00014	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.62e-06	0.00014	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	2.62e-06	0.00014	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.62e-06	0.00014	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	2.62e-06	0.00014	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.6e-06	0.000139	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—INS—type 2 diabetes mellitus	2.59e-06	0.000138	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.55e-06	0.000136	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	2.53e-06	0.000135	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.53e-06	0.000135	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.51e-06	0.000134	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NOS3—type 2 diabetes mellitus	2.51e-06	0.000134	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	2.51e-06	0.000134	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.5e-06	0.000134	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.5e-06	0.000134	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	2.5e-06	0.000133	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.49e-06	0.000133	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	2.48e-06	0.000132	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.48e-06	0.000132	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	2.46e-06	0.000132	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	2.45e-06	0.000131	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	2.45e-06	0.000131	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	2.44e-06	0.00013	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	2.44e-06	0.00013	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	2.44e-06	0.00013	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	2.44e-06	0.00013	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	2.43e-06	0.00013	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	2.4e-06	0.000128	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.39e-06	0.000128	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.39e-06	0.000127	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	2.39e-06	0.000127	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	2.39e-06	0.000127	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	2.39e-06	0.000127	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.38e-06	0.000127	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	2.37e-06	0.000127	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	2.36e-06	0.000126	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.35e-06	0.000125	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	2.34e-06	0.000125	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	2.33e-06	0.000125	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	2.33e-06	0.000124	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	2.3e-06	0.000123	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—type 2 diabetes mellitus	2.3e-06	0.000123	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	2.3e-06	0.000123	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.28e-06	0.000122	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.27e-06	0.000121	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.27e-06	0.000121	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	2.25e-06	0.00012	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.24e-06	0.00012	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.23e-06	0.000119	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	2.21e-06	0.000118	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.2e-06	0.000118	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	2.2e-06	0.000117	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	2.18e-06	0.000116	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.18e-06	0.000116	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.15e-06	0.000115	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	2.14e-06	0.000114	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	2.14e-06	0.000114	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	2.14e-06	0.000114	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	2.14e-06	0.000114	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.14e-06	0.000114	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	2.13e-06	0.000114	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	2.13e-06	0.000114	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.11e-06	0.000113	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	2.1e-06	0.000112	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	2.09e-06	0.000112	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	2.08e-06	0.000111	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	2.08e-06	0.000111	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	2.08e-06	0.000111	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	2.08e-06	0.000111	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.07e-06	0.00011	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.05e-06	0.00011	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	2.04e-06	0.000109	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	2.03e-06	0.000109	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	2.03e-06	0.000108	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.03e-06	0.000108	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	2e-06	0.000107	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.99e-06	0.000106	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.99e-06	0.000106	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	1.99e-06	0.000106	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.97e-06	0.000105	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	1.96e-06	0.000104	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.95e-06	0.000104	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.94e-06	0.000104	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.94e-06	0.000104	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.94e-06	0.000104	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.94e-06	0.000104	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.94e-06	0.000104	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	1.93e-06	0.000103	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	1.93e-06	0.000103	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.93e-06	0.000103	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	1.93e-06	0.000103	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.93e-06	0.000103	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.91e-06	0.000102	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	1.9e-06	0.000101	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.89e-06	0.000101	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	1.89e-06	0.000101	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	1.89e-06	0.000101	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.88e-06	0.0001	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.87e-06	0.0001	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	1.87e-06	9.97e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.86e-06	9.95e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.86e-06	9.95e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.86e-06	9.95e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	1.85e-06	9.91e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	1.85e-06	9.91e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.83e-06	9.77e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.82e-06	9.72e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.81e-06	9.68e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.8e-06	9.62e-05	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.78e-06	9.49e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.77e-06	9.48e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.77e-06	9.43e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.75e-06	9.33e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.74e-06	9.3e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.74e-06	9.3e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.74e-06	9.3e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.71e-06	9.13e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.7e-06	9.1e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.69e-06	9.05e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.69e-06	9e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.69e-06	9e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.68e-06	8.96e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.67e-06	8.92e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.66e-06	8.85e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	1.65e-06	8.79e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.64e-06	8.78e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.63e-06	8.73e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.62e-06	8.63e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.62e-06	8.63e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—INS—type 2 diabetes mellitus	1.61e-06	8.62e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	1.6e-06	8.54e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.6e-06	8.54e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.59e-06	8.5e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	1.59e-06	8.5e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.57e-06	8.41e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.57e-06	8.41e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	1.57e-06	8.39e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.54e-06	8.2e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.53e-06	8.16e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	1.52e-06	8.14e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.51e-06	8.06e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.51e-06	8.06e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.5e-06	8.01e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.48e-06	7.92e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	1.48e-06	7.9e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.47e-06	7.86e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	1.46e-06	7.77e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	1.42e-06	7.61e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	1.42e-06	7.58e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	1.42e-06	7.56e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.42e-06	7.56e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.39e-06	7.44e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.39e-06	7.44e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.39e-06	7.4e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	1.38e-06	7.39e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.37e-06	7.31e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	1.37e-06	7.29e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.33e-06	7.09e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	1.31e-06	7e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.3e-06	6.95e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.3e-06	6.95e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.3e-06	6.92e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	1.29e-06	6.91e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.29e-06	6.9e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	1.29e-06	6.87e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.28e-06	6.82e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.27e-06	6.77e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	1.25e-06	6.65e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.24e-06	6.63e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.24e-06	6.63e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.24e-06	6.61e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	1.22e-06	6.54e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	1.22e-06	6.52e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.21e-06	6.45e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	1.21e-06	6.44e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.2e-06	6.43e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.19e-06	6.35e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.18e-06	6.33e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.16e-06	6.19e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.16e-06	6.17e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—type 2 diabetes mellitus	1.15e-06	6.17e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.14e-06	6.1e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.13e-06	6.04e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.13e-06	6.01e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.12e-06	5.98e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.11e-06	5.94e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.08e-06	5.79e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.07e-06	5.7e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.07e-06	5.7e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.06e-06	5.68e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.06e-06	5.68e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.05e-06	5.61e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.05e-06	5.59e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.04e-06	5.57e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.04e-06	5.57e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.01e-06	5.41e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	9.97e-07	5.32e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	9.93e-07	5.3e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	9.82e-07	5.24e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	9.56e-07	5.1e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	9.26e-07	4.94e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	9.14e-07	4.88e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	9.14e-07	4.88e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—INS—type 2 diabetes mellitus	9.08e-07	4.85e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	8.65e-07	4.62e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	8.48e-07	4.53e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	8.36e-07	4.46e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	8.33e-07	4.45e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	7.96e-07	4.25e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.96e-07	4.25e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	7.78e-07	4.15e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	7.44e-07	3.97e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	7.44e-07	3.97e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	7.28e-07	3.89e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	6.8e-07	3.63e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	6.5e-07	3.47e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	4.2e-07	2.24e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.66e-07	1.95e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.42e-07	1.83e-05	CbGpPWpGaD
